Fujita K - Search Results

1

Fujita K, Matsushita M, Banno E, De Velasco MA, Hatano K, Nonomura N, Uemura H. Fujita K, et al. Int J Urol. 2022 Aug;29(8):793-798. doi: 10.1111/iju.14894. Epub 2022 Apr 6. Int J Urol. 2022. PMID: 35388531 Review.

2

Primary signet ring cell carcinoma of the prostate: report and review of 42 cases.

Fujita K, Sugao H, Gotoh T, Yokomizo S, Itoh Y. Fujita K, et al. Int J Urol. 2004 Mar;11(3):178-81. doi: 10.1111/j.1442-2042.2003.00763.x. Int J Urol. 2004. PMID: 15009368 Free article. Review.

3

Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy.

Fujita K, Tsujimura A, Miyagawa Y, Kiuchi H, Matsuoka Y, Takao T, Takada S, Nonomura N, Okuyama A. Fujita K, et al. Cancer Res. 2006 Dec 1;66(23):11166-71. doi: 10.1158/0008-5472.CAN-06-2326. Cancer Res. 2006. PMID: 17145860

4

Effect of human leukemia cells in testicular tissues grafted into immunodeficient mice.

Fujita K, Tsujimura A, Hirai T, Ohta H, Matsuoka Y, Miyagawa Y, Takao T, Takada S, Nonomura N, Okuyama A. Fujita K, et al. Int J Urol. 2008 Aug;15(8):733-8. doi: 10.1111/j.1442-2042.2008.02087.x. Epub 2008 Jun 16. Int J Urol. 2008. PMID: 18564206

5

Urological surgery in patients aged 80 years and older: a 30-year retrospective clinical study.

Takao T, Tsujimura A, Kiuchi H, Komori K, Fujita K, Miyagawa Y, Takada S, Nonomura N, Okuyama A. Takao T, et al. Among authors: fujita k. Int J Urol. 2008 Sep;15(9):789-93. doi: 10.1111/j.1442-2042.2008.02110.x. Epub 2008 Jul 10. Int J Urol. 2008. PMID: 18651864

6

Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy.

Fujita K, Nakayama M, Nakai Y, Takayama H, Nishimura K, Ujike T, Nishimura K, Aozasa K, Okuyama A, Nonomura N. Fujita K, et al. Cancer Sci. 2009 Jun;100(6):1047-50. doi: 10.1111/j.1349-7006.2009.01146.x. Epub 2009 Feb 25. Cancer Sci. 2009. PMID: 19385972 Free PMC article.

7

Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc.

Hatano K, Yamaguchi S, Nimura K, Murakami K, Nagahara A, Fujita K, Uemura M, Nakai Y, Tsuchiya M, Nakayama M, Nonomura N, Kaneda Y. Hatano K, et al. Among authors: fujita k. Mol Cancer Res. 2013 Sep;11(9):1088-100. doi: 10.1158/1541-7786.MCR-13-0029-T. Epub 2013 Jun 20. Mol Cancer Res. 2013. PMID: 23788635 Free article.

8

Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma.

Sato M, Nakai Y, Nakata W, Yoshida T, Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H, Nonomura N. Sato M, et al. Among authors: fujita k. Int J Urol. 2014 Feb;21(2):130-4. doi: 10.1111/iju.12231. Epub 2013 Aug 15. Int J Urol. 2014. PMID: 23944647

9

White blood cell count is positively associated with benign prostatic hyperplasia.

Fujita K, Hosomi M, Nakagawa M, Tanigawa G, Imamura R, Uemura M, Nakai Y, Takayama H, Yamaguchi S, Nonomura N. Fujita K, et al. Int J Urol. 2014 Mar;21(3):308-12. doi: 10.1111/iju.12243. Epub 2013 Aug 26. Int J Urol. 2014. PMID: 23980666

10

EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.

Sato M, Nakai Y, Nakata W, Yoshida T, Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H, Nonomura N. Sato M, et al. Among authors: fujita k. PLoS One. 2013 Sep 20;8(9):e74313. doi: 10.1371/journal.pone.0074313. eCollection 2013. PLoS One. 2013. PMID: 24073208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,224 results

Search Page

Filters